Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Kourtney Kardashian's new weight loss pill
GLP-1 pills are coming, and they could revolutionize weight-loss treatment
At least a dozen experimental weight-loss drugs designed to be taken as pills are working their way through clinical trials, with the most advanced now in the third and final stage of testing.
Kourtney Kardashian Is Selling a Scam Weight Loss Treatment That Says "GLP-1" on the Bottle But Isn't a GLP-1
As GLP-1 weight loss drugs fly off shelves, Kourtney Kardashian Barker is getting in on the hustle — well, sort of. As Business Insider and other outlets report, Kardashian Barker's brand Lemme has launched a new line of oral supplements marketed as an alternative to actual glucagon-like peptide-1 drugs like Ozempic and Wegovy.
Kourtney Kardashian Barker Just Launched a "Natural" GLP-1 Weight-Loss Supplement—but Is It Safe?
Boasted as being a “breakthrough capsule formula designed to boost GLP-1 hormone levels, reduce hunger and cravings and support healthy weight management,” the supplement contains three clinically-studied, patented ingredients: Eriomin® Lemon Fruit Extract, Supresa® Saffron Extract, and Morosil™ Red Orange Fruit Extract.
Kourtney Kardashian announces new Ozempic-style weight loss capsules; we find out if they are safe and effective
Kourtney Kardashian Barker’s wellness brand has introduced a new product offering a natural alternative to popular weight loss drugs like Ozempic. This supplement promises to support metabolic health,
Kourtney Kardashian's new weight loss pill: Innovative or ineffective?
Kourtney Kardashian showcased her new signature product, which she describes as a "breakthrough innovation" in weight loss pills. Will you be tempted? Each of the entrepreneurial Kardashian-Jenner sisters not only represents a brand but also owns their own businesses.
21h
on MSN
GLP-1 drugs could help prevent 34,000 heart attacks and strokes in the US each year, research suggests
Certain blockbuster weight-loss drugs have been found to protect the heart in significant ways, and new research suggests ...
16h
on MSN
ResMed Stock Is S&P 500’s Worst Performer. GLP-1 Drugs Are a Risk.
Wolfe Research downgraded shares of the maker of sleep-apnea airway machines to Underperform from Peer Perform.
18h
on MSN
This Small-Cap Stock Has a Promising GLP-1 Drug Which Could Rival Novo Nordisk and Eli Lilly's Weight-Loss Treatments
It's currently dominated by a few big names in Eli Lilly and Novo Nordisk, but that can change drastically in the future. The ...
Medpage Today on MSN
2d
GLP-1 Drugs in MASLD Tied to Lower Risk of Cirrhosis, Death
GLP-1 receptor agonist use was associated with a reduced risk of progressing to cirrhosis and related complications in ...
Becker's Hospital Review
17h
GLP-1 weight loss pills are in the works: What to know
GLP-1
weight loss medications like Ozempic and Wegovy have become blockbuster drugs, but the need for weekly injections has limited their use. This may soon change, as several oral versions are ...
2d
A woman lost 190 pounds from exercise, food journaling, and GLP-1 medication. She's now training for a marathon.
Jennifer Brown lost weight from walking every day and food journaling. It motivated her to start running a mile every day.
Fierce Healthcare
1d
Noom to offer compounded GLP-1 drug to rival pricey branded weight loss meds
Noom is the latest digital health company to jump into the off-label weight loss drug market to make medications more ...
7d
GLP-1 hybrid drug being tested as weight-loss aid
The manufacturer of Ozempic is testing amycretin, an experimental weight-loss pill that appears to help people quickly shed ...
6d
Noom Introduces Industry-First $149 Compounded GLP-1 with a Taper-Off Guarantee, Offering a Sustainable Approach to Long-Term Weight Loss
Starting price of $149 offers improved accessibility compared to market prices of brand-name medications which can be 8x ...
19h
Hims & Hers to Offer Access to Compounded GLP-1 Injections for as Low as $99/Month to U.S. Military, Veterans, Teachers, Nurses and First Responders
Hims & Hers Health, Inc. ("Hims & Hers", NYSE: HIMS), the leading health and wellness platform committed to breaking down ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Related topics
Weight loss
ResMed
Kourtney Kardashian
Ozempic
Eli Lilly and Company
Feedback